Technical Analysis for HROW - Harrow Health, Inc.

Grade Last Price % Change Price Change
C 8.75 2.94% 0.25
HROW closed up 2.94 percent on Tuesday, July 27, 2021, on 73 percent of normal volume. Note that the stock is in overbought territory based on its Slow Stochastic indicator (14, 3, 3) -- sideways movement or a pullback should not be unexpected.
Earnings due: Aug 9
*** please verify all earnings dates ***

Trend Table & Recent EOD Trading Signals

ADX Long Term Intermediate Term Short Term
Weak or Absent Up Down Up
Historical HROW trend table...

Date Alert Name Type % Chg
Non-ADX 1,2,3,4 Bearish Bearish Swing Setup 0.00%
Stochastic Reached Overbought Strength 0.00%
Wide Bands Range Expansion 0.00%
Overbought Stochastic Strength 0.00%
Up 3 Days in a Row Strength 0.00%
Up 4 Days in a Row Strength 0.00%
Up 5 Days in a Row Strength 0.00%
Non-ADX 1,2,3,4 Bearish Bearish Swing Setup 2.94%
Crossed Above 20 DMA Bullish 2.94%
MACD Bullish Signal Line Cross Bullish 2.94%
Older End-of-Day Signals for HROW ...

   Recent Intraday Alerts -- Get these alerts pushed to you via our Mobile App

Alert Time
Up 3% about 4 hours ago
Rose Above Previous Day's High about 4 hours ago
Up 2% about 4 hours ago
Possible NR7 about 4 hours ago
60 Minute Opening Range Breakout about 5 hours ago
View Earlier Intraday Alerts

Get this analysis on your stocks daily!

Let us help you stay on top of your investments. We will alert you to important technical developments on your portfolio & watchlist.

Profile

Harrow Health, Inc. Description

Harrow Health, Inc., formerly Imprimis Pharmaceuticals, Inc., is engaged in the development, production and dispensing of compounded pharmaceuticals. The Company operates through the business of developing drug therapies and providing such therapies through sterile and non-sterile pharmaceutical compounding services segment. The Company owns, markets and dispenses a portfolio of compounded therapeutic in several therapeutic areas, including ophthalmology, urology, otolaryngology and infectious diseases. The Company is also developing Custom Compounding Choice business, which is focused on developing and dispensing a portfolio of non-proprietary compounded drugs for humans and animals in therapeutic areas that may be overlooked by commercial pharmaceutical companies. The Company also offers customizable compounding products that consist of sterile injectable and non-sterile integrative medicine therapies that are used in various therapeutic areas.


Classification

Sector: Healthcare
Industry: Drug Manufacturers - Specialty & Generic
Keywords: Pharmaceutical Infectious Diseases Pharmacy Pharmaceuticals Ophthalmology Urology Pharmaceutical Sciences Drug Therapies Compounding

Is HROW a Buy, Sell or Hold?

Indicator Bull Case Neutral / Hold Bear Case
50 DMA
200 DMA
ADX Trend
Oversold / Overbought
Relative Strength

Indicators

Indicator Value
52 Week High 11.24
52 Week Low 4.65
Average Volume 276,727
200-Day Moving Average 7.55
50-Day Moving Average 8.88
20-Day Moving Average 8.18
10-Day Moving Average 7.69
Average True Range 0.51
ADX 20.88
+DI 29.94
-DI 22.19
Chandelier Exit (Long, 3 ATRs) 9.23
Chandelier Exit (Short, 3 ATRs) 8.42
Upper Bollinger Bands 9.72
Lower Bollinger Band 6.64
Percent B (%b) 0.69
BandWidth 37.70
MACD Line -0.21
MACD Signal Line -0.33
MACD Histogram 0.1169
Fundamentals Value
Market Cap 225.28 Million
Num Shares 25.7 Million
EPS 0.58
Price-to-Earnings (P/E) Ratio 15.06
Price-to-Sales 3.17
Price-to-Book 5.61
Pivot Point Level Traditional / Classic Fibonacci Demark Woodie Camarilla
Resistance 4 (R4) 9.47
Resistance 3 (R3) 9.43 9.14 9.35
Resistance 2 (R2) 9.14 8.96 9.16 9.31
Resistance 1 (R1) 8.95 8.85 9.04 8.99 9.27
Pivot Point 8.66 8.66 8.71 8.69 8.66
Support 1 (S1) 8.47 8.48 8.57 8.51 8.23
Support 2 (S2) 8.18 8.37 8.21 8.19
Support 3 (S3) 7.99 8.18 8.15
Support 4 (S4) 8.03